Efficacy and Safety of Gefapixant (MK-7264) in Adult Participants With Recent Onset Chronic Cough (MK-7264-043)
Clinical trial NCT04193202 · COMPLETED
Trial details
- NCT number
- NCT04193202
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-21
- Primary completion
- 2021-10-19
- Enrollment
- 419
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.